Alkermes (ALKS) Current Leases (2019 - 2026)
Alkermes' (ALKS) quarterly Current Leases came in at $7.6 million in Q1 2026, up 20.44% year-on-year from $6.3 million in Q1 2025, and up 12.32% on a QoQ basis from $6.7 million in Q4 2025.
Alkermes (ALKS) Current Leases (2019 - 2026) Analysis & Trends
Alkermes (ALKS) has 8 years of Current Leases data on file, last reported at $7.6 million in Q1 2026.
- On a quarterly basis, Current Leases rose 20.44% year-over-year to $7.6 million in Q1 2026; TTM through Mar 2026 was $7.6 million, a 20.44% increase from a year earlier, with the FY2025 full-year figure at $6.7 million, up 9.41% from the prior year.
- Current Leases for Q1 2026 stood at $7.6 million, up from $6.7 million in the prior quarter.
- Over the last five years, Current Leases for ALKS reached as high as $16.1 million in Q1 2022 and fell as low as $5.7 million in Q4 2023.
- Historically, Current Leases has averaged $9.8 million across 5 years, with a median of $6.7 million in 2025.
- Across the five-year window, Current Leases sank 61.38% in 2024 and gained 20.44% in 2026, its largest moves.
- Year by year, Current Leases stood at $9.9 million in 2022, then plunged by 41.83% to $5.7 million in 2023, then climbed by 7.31% to $6.2 million in 2024, then increased by 9.41% to $6.7 million in 2025, then advanced by 12.32% to $7.6 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $7.6 million in Q1 2026, $6.7 million in Q4 2025, and $6.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | 7.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.58 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 6.63 Mn |
| Jun 30, 2025 | 6.46 Mn |
| Mar 31, 2025 | 6.29 Mn |
| Dec 31, 2024 | 6.17 Mn |
| Sep 30, 2024 | 6.15 Mn |
| Jun 30, 2024 | 6.01 Mn |
| Mar 31, 2024 | 5.91 Mn |
| Dec 31, 2023 | 5.75 Mn |
| Sep 30, 2023 | 15.06 Mn |
| Jun 30, 2023 | 15.19 Mn |
| Mar 31, 2023 | 15.30 Mn |
| Dec 31, 2022 | 9.88 Mn |
| Sep 30, 2022 | 15.76 Mn |
| Jun 30, 2022 | 15.94 Mn |
| Mar 31, 2022 | 16.14 Mn |
| Dec 31, 2021 | 16.24 Mn |
| Sep 30, 2021 | 15.55 Mn |
| Jun 30, 2021 | 15.85 Mn |